Vireo Health LLC entered into binding letter of intent to acquire Darien Business Development Corp. (TSXV:DBD.H) in a reverse merger transaction on January 10, 2019. As of February 13, 2019, Vireo Health LLC entered into an agreement to acquire Darien Business Development Corp. (TSXV:DBD.H) in a reverse merger transaction. Under the transaction, Darien Business Development would acquire all of the issued and outstanding shares of U.S. based company in consideration for Darien Business Development's shares that on issuance would constitute a substantial majority of Darien Business Development's equity. The transaction will constitute a change of business for Darien Business Development. Darien will change its name to Vireo Health International, Inc. post-acquisition. The board of directors of resulting issuer be set at seven directors and consist initially of seven directors and be comprised of Kyle Kingsley as Chairman and Amber Shimpa, Ari Hoffnung, Chad Martinson, Judd Nordquist, Amy Langer and Chelsea Grayson as directors The deal is subject to satisfactory due diligence, Darien Business Development to consolidate its currently issued and outstanding common shares in an amount to be agreed between Darien Business Development and undisclosed U.S. based company upon the final determination of the valuation of undisclosed U.S. based company, requisite corporate approvals, negotiation of definitive agreement, exercise or cancellation of all outstanding stock options, cancellation all management contracts and compensation agreements with directors and officers of Darien Business Development, replacement of Darien Business Development's Board of Directors with representatives nominated by U.S. based company, and change the management of Darien Business Development, settlement of the balance of liabilities of Darien Business Development, obtaining all necessary regulatory approvals, approval of shareholders of Vireo and Darien Business Development, Vireo shall be satisfied in its sole discretion that at the time of the completion of the transaction, Darien Business Development has a cash balance of not less than CAD 0 and delisting of the shares of Darien Business Development from the TSX Venture Exchange and list the shares on CSE and other customary closing conditions. The transaction is also subject to private placement of CAD 3 million by Vireo Health. As per announcement on February 11, 2019, Darien will hold annual and special shareholders meeting on March 8, 2019 to approve the transaction. As of March 13, 2019, Darien Business shareholders approved the transaction. The transaction is expected to close later in the first quarter of 2019. As per the announcement made on March 13, 2019, the transaction is expected to close in March 2019. Computershare Investor Services Inc acted as proxy solicitor to Darien in the transaction. Frank DeLuca of Cassels Brock & Blackwell LLP acted as legal advisor for Vireo.